Skip to content
Recall Observatory FDA recall evidence

Drug product

Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

D-1878-2019

September 17, 2019

Class II

Product summary

Firm
Akorn, Inc.
Event
Event 83721
Status
Terminated
Classification
Class II
Quantity
10,543 tubes
Official record key
drug-enforcement:D-1878-2019

Official wording

Reason: cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.

Code information: Lot #: 9B21A, Exp. 1/2022

Distribution pattern: Nationwide within the United States and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    particulate matter
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations